These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34064698)

  • 1. Stability and In Vitro Aerodynamic Studies of Inhalation Powders Containing Ciprofloxacin Hydrochloride Applying Different DPI Capsule Types.
    Benke E; Varga P; Szabó-Révész P; Ambrus R
    Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34064698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability test of novel combined formulated dry powder inhalation system containing antibiotic: physical characterization and
    Benke E; Farkas Á; Balásházy I; Szabó-Révész P; Ambrus R
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1369-1378. PubMed ID: 31096805
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of capsule type on aerodynamic performance of inhalation products: A case study using a formoterol-lactose binary or ternary blend.
    Wauthoz N; Hennia I; Ecenarro S; Amighi K
    Int J Pharm; 2018 Dec; 553(1-2):47-56. PubMed ID: 30321640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel dry powder inhaler formulation containing antibiotic using combined technology to improve aerodynamic properties.
    Ambrus R; Benke E; Farkas Á; Balásházy I; Szabó-Révész P
    Eur J Pharm Sci; 2018 Oct; 123():20-27. PubMed ID: 30016647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of HPMC Inhalation-Grade Capsules and Their Effect on Aerosol Performance Using Budesonide and Rifampicin DPI Formulations.
    Ding L; Brunaugh AD; Thakkar R; Lee C; Zhao QJ; Kalafat J; Maniruzzaman M; Smyth HDC
    AAPS PharmSciTech; 2022 Jan; 23(1):52. PubMed ID: 35018574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of inner physical properties on powder adhesion in inhalation capsules in case of a high resistance device.
    Otake H; Minami M; Yamaguchi M; Akiyama S; Inaba K; Nagai N
    Exp Ther Med; 2021 Dec; 22(6):1353. PubMed ID: 34659499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation of novel dry powder inhalation for fluticasone propionate and salmeterol xinafoate with capsule-based device.
    Kim KS; Kim JH; Jin SG; Kim DW; Kim JO; Yong CS; Youn YS; Oh KT; Woo JS; Choi HG
    Pharm Dev Technol; 2018 Feb; 23(2):158-166. PubMed ID: 28612675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of ethanol on the habit and
    Benke E; Winter C; Szabó-Révész P; Roblegg E; Ambrus R
    Asian J Pharm Sci; 2021 Jul; 16(4):471-482. PubMed ID: 34703496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Physico-mechanical Properties and Electrostatic Charging Behavior of Different Capsule Types for Inhalation Under Distinct Environmental Conditions.
    Pinto JT; Wutscher T; Stankovic-Brandl M; Zellnitz S; Biserni S; Mercandelli A; Kobler M; Buttini F; Andrade L; Daza V; Ecenarro S; Canalejas L; Paudel A
    AAPS PharmSciTech; 2020 May; 21(4):128. PubMed ID: 32399597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride.
    Karimi K; Katona G; Csóka I; Ambrus R
    J Pharm Biomed Anal; 2018 Jan; 148():73-79. PubMed ID: 28965047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerodynamic properties and in silico deposition of meloxicam potassium incorporated in a carrier-free DPI pulmonary system.
    Chvatal A; Farkas Á; Balásházy I; Szabó-Révész P; Ambrus R
    Int J Pharm; 2017 Mar; 520(1-2):70-78. PubMed ID: 28161667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and evaluation of carrier-free dry powder inhaler containing sildenafil.
    Nguyen TT; Yi EJ; Hwang KM; Cho CH; Park CW; Kim JY; Rhee YS; Park ES
    Drug Deliv Transl Res; 2019 Feb; 9(1):319-333. PubMed ID: 30276666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carrier-based dry powder inhalation: Impact of carrier modification on capsule filling processability and in vitro aerodynamic performance.
    Faulhammer E; Wahl V; Zellnitz S; Khinast JG; Paudel A
    Int J Pharm; 2015 Aug; 491(1-2):231-42. PubMed ID: 26136200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the motion of hard-shell capsules in dry powder inhalers.
    Benque B; Khinast JG
    Int J Pharm; 2019 Aug; 567():118481. PubMed ID: 31260784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an Innovative, Carrier-Based Dry Powder Inhalation Formulation Containing Spray-Dried Meloxicam Potassium to Improve the In Vitro and In Silico Aerodynamic Properties.
    Benke E; Farkas Á; Szabó-Révész P; Ambrus R
    Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32532040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Powder, capsule and device: An imperative ménage à trois for respirable dry powders.
    Schoubben A; Blasi P; Giontella A; Giovagnoli S; Ricci M
    Int J Pharm; 2015 Oct; 494(1):40-8. PubMed ID: 26255220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a New High-Dose Dry Powder Inhaler (DPI) Based on a Fluidized Bed Design.
    Farkas DR; Hindle M; Longest PW
    Ann Biomed Eng; 2015 Nov; 43(11):2804-15. PubMed ID: 25986955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.
    Singh DJ; Jain RR; Soni PS; Abdul S; Darshana H; Gaikwad RV; Menon MD
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):254-67. PubMed ID: 25517187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability and pharmacokinetic properties of ciprofloxacin dry powder for inhalation in patients with cystic fibrosis: a phase I, randomized, dose-escalation study.
    Stass H; Weimann B; Nagelschmitz J; Rolinck-Werninghaus C; Staab D
    Clin Ther; 2013 Oct; 35(10):1571-81. PubMed ID: 24054830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical tools and control of internal lubricant content of inhalation grade HPMC capsules during manufacture.
    Ayala G; Díez F; Gassó MT; Jones BE; Martín-Portugués R; Ramiro-Aparicio J
    Int J Pharm; 2016 Apr; 503(1-2):36-40. PubMed ID: 26899981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.